ADVERSE REACTIONS SECTION.
Sincerus Florida, LLC. Adverse reactions. s.
Citing DrugCentral © 2024. License
COMPONENTS.
Active, inactive. x.
Citing DrugCentral © 2024. License
INSTRUCTIONS FOR USE SECTION.
Directions for use. e.
Citing DrugCentral © 2024. License
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.
NDC 72934-2093-2 HYALURONIC ACID SODIUM SALT 0.5% TAZAROTENE 0.05%. Cream 30gm.. v.
Citing DrugCentral © 2024. License